About HK Broad Capital
Company Overview
HK Broad Capital is a financial services entity registered in Hong Kong, with an official domain of hkbcl.com. According to known records, the company was established on 21 April 2020, and its registered address is Room 1135, 11/F Grand Millennium Plaza, 181 Queen’s Road Central, Sheung Wan, Hong Kong.
Despite being incorporated in a major financial hub, the firm does not appear to hold any regulatory licences from the Hong Kong Securities and Futures Commission (SFC) or any other recognised financial authority. This absence of regulatory oversight is a significant factor for potential clients to consider.
Regulatory Status
FXCanary's research indicates that HK Broad Capital has no regulators on file. The company is not listed on any public register of authorised financial institutions in Hong Kong or elsewhere. This means that the firm is not subject to the capital requirements, client money protections, or conduct-of-business rules that apply to licensed brokers.
For traders, this lack of regulation removes a key layer of safety. In the event of a dispute or the firm's insolvency, there is no ombudsman or compensation scheme to turn to. Any engagement with HK Broad Capital would be entirely at the client’s own risk.
Risk Considerations
Given the absence of regulatory oversight, HK Broad Capital carries a high inherent risk profile. The FXCanary Scam Risk Score is 48 out of 100, which falls into the 'Guarded' category. This score reflects the limited public information and the lack of independent verification of the company's operations.
Potential clients should conduct thorough due diligence before considering any services from this entity. It is crucial to verify the firm's claims independently and to understand that without regulation, there are no formal channels for recourse if issues arise. Traders are strongly advised to seek out brokers that are licensed by reputable authorities.
Overview compiled by FXCanary from regulatory records and public data. full HK Broad Capital review